PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 214 filers reported holding PDL BIOPHARMA INC in Q1 2015. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $330,000 | -19.1% | 140,847 | +1.5% | 0.00% | -50.0% |
| Q1 2018 | $408,000 | +55.7% | 138,708 | +44.8% | 0.00% | +100.0% |
| Q4 2017 | $262,000 | +2281.8% | 95,791 | +2094.0% | 0.00% | – |
| Q2 2017 | $11,000 | -52.2% | 4,366 | -57.2% | 0.00% | – |
| Q1 2017 | $23,000 | -96.9% | 10,206 | -97.1% | 0.00% | -100.0% |
| Q4 2016 | $734,000 | +14.9% | 346,013 | +317.7% | 0.00% | 0.0% |
| Q4 2014 | $639,000 | -62.3% | 82,829 | -63.5% | 0.00% | -62.5% |
| Q3 2014 | $1,693,000 | -27.9% | 226,704 | -6.5% | 0.01% | -27.3% |
| Q2 2014 | $2,347,000 | -52.7% | 242,470 | -59.4% | 0.01% | -52.2% |
| Q1 2014 | $4,965,000 | +19.2% | 597,489 | +21.1% | 0.02% | +21.1% |
| Q4 2013 | $4,164,000 | +15.3% | 493,357 | +8.9% | 0.02% | +5.6% |
| Q3 2013 | $3,611,000 | -0.0% | 453,074 | -3.2% | 0.02% | 0.0% |
| Q2 2013 | $3,612,000 | – | 467,898 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |